COVID 19
FDA recommends inclusion of BA.4, BA.5 subvariants in COVID boosters
2022.06.30 17:29
FDA recommends inclusion of BA.4
Budrigannews – The U.S. Food and Drug Administration on Thursday recommended the inclusion of Omicron BA.4 and BA.5 subvariants as a part of COVID-19 booster doses.
The regulators move comes after advisers to the health regulator on Tuesday recommended a change in the design of COVID-19 booster shots this fall in order to combat more recently circulating variants of the coronavirus.
